Emulating Randomized Clinical Trials with Nonrandomized Real-World Evidence Studies: First Results from the RCT DUPLICATE Initiative
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emulating Randomized Clinical Trials with Nonrandomized Real-World Evidence Studies: First Results from the RCT DUPLICATE Initiative
Authors
Keywords
-
Journal
CIRCULATION
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-12-17
DOI
10.1161/circulationaha.120.051718
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emulation Differences vs. Biases When Calibrating Real‐World Evidence Findings Against Randomized Controlled Trials
- (2020) Jessica M. Franklin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?
- (2020) Jim Slattery et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov
- (2020) Krishna Pundi et al. JAMA Internal Medicine
- Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims
- (2020) Rishi J. Desai et al. Journal of the American Heart Association
- Evaluating the Use of Nonrandomized Real World Data Analyses for Regulatory Decision Making
- (2019) Jessica M. Franklin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Real‐World Evidence of Treatment Effects: The Useful and the Misleading
- (2019) Sebastian Schneeweiss CLINICAL PHARMACOLOGY & THERAPEUTICS
- Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride
- (2019) Elisabetta Patorno et al. DIABETES CARE
- Nonrandomized real‐world evidence to support regulatory decision‐making: Process for a randomized trial replication project
- (2019) Jessica M. Franklin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
- (2019) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records
- (2018) Elisabetta Patorno et al. DIABETES OBESITY & METABOLISM
- Out-of-system Care and Recording of Patient Characteristics Critical for Comparative Effectiveness Research
- (2018) Kueiyu Joshua Lin et al. EPIDEMIOLOGY
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multidimensional Evidence Generation and FDA Regulatory Decision Making
- (2017) Jonathan P. Jarow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
- (2017) Marc L. Berger et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study
- (2017) Seoyoung C. Kim et al. Arthritis & Rheumatology
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
- (2016) Miguel A. Hernán et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.
- (2016) SV Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
- (2016) Miguel A. Hernán et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014
- (2016) Anthony J Hatswell et al. BMJ Open
- Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey
- (2016) Lars G Hemkens et al. BMJ-British Medical Journal
- Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey
- (2016) Lars G Hemkens et al. BMJ-British Medical Journal
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Treatment Effect Estimates From Prospective Nonrandomized Studies With Propensity Score Analysis and Randomized Controlled Trials of Surgical Procedures
- (2013) Guillaume Lonjon et al. ANNALS OF SURGERY
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes
- (2012) Issa J. Dahabreh et al. EUROPEAN HEART JOURNAL
- One-to-many propensity score matching in cohort studies
- (2012) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Beyond the intention-to-treat in comparative effectiveness research
- (2011) Miguel A Hernán et al. Clinical Trials
- Participation in a Clinical Trial Enhances Adherence and Persistence to Treatment
- (2011) Hein A.W. van Onzenoort et al. HYPERTENSION
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started